Results 21 to 30 of about 716,015 (305)

Assessment of low-dose cisplatin as a model of nausea and emesis in beagle dogs, potential for repeated administration [PDF]

open access: yes, 2014
Cisplatin is a highly emetogenic cancer chemotherapy agent, which is often used to induce nausea and emesis in animal models. The cytotoxic properties of cisplatin also cause adverse events that negatively impact on animal welfare preventing repeated ...
A Tidholm   +46 more
core   +3 more sources

Chemotherapy-induced nausea and vomiting: A narrative review to inform dietetics practice [PDF]

open access: yes, 2016
Chemotherapy-induced nausea and vomiting (CINV) are common nutrition-impact symptoms experienced by cancer patients. They exert a detrimental effect on dietary intake, risk of malnutrition and quality of life.
Isenring, Liz   +4 more
core   +3 more sources

Motion sickness and migraine: optokinetic stimulation increases scalp tenderness, pain sensitivity in the fingers and photophobia [PDF]

open access: yes, 2002
The aim of this study was to determine whether scalp tenderness and photophobia, two well-recognized symptoms of migraine, develop during the motion sickness induced by optokinetic stimulation.
Drummond, P.D.
core   +2 more sources

Combination Antiemetic Therapy for Chemotherapy-Induced Nausea and Vomiting in Patients with NSCLC Receiving Carboplatin-Based Chemotherapy

open access: yesCancer Management and Research, 2022
Mototsugu Shimokawa,1,2,* Naoki Haratake,3,* Kazuki Takada,4 Gouji Toyokawa,5 Shinkichi Takamori,6 Fumitaka Mizuki,7 Tomoyoshi Takenaka,3 Toshinobu Hayashi8 1Department of Biostatistics, Graduate School of Medicine, Yamaguchi University ...
Shimokawa M   +7 more
doaj  

Cannabinoid hyperemesis and the cyclic vomiting syndrome in adults: recognition, diagnosis, acute and long-term treatment

open access: yesGMS German Medical Science, 2017
The cannabinoid hyperemesis syndrome (CHS) and the cyclic vomiting syndrome in adults (CVS) are both characterized by recurrent episodes of heavy nausea, vomiting and frequently abdominal pain. Both syndromes are barely known among physicians. Literature
Blumentrath, Christian G.   +2 more
doaj   +1 more source

Recalling the severity of nausea and vomiting of pregnancy – a study using Pregnancy-Unique Quantification of Emesis Questionnaire

open access: yesJournal of Obstetrics and Gynaecology, 2023
The accuracy of the recall of the severity of nausea and vomiting of pregnancy (NVP) with Pregnancy-Unique Quantification of Emesis (PUQE) questionnaire has been questioned.
Linda Laitinen   +4 more
doaj   +1 more source

Frequency of Predisposing Factor of Nausea and Vomiting After Chest Surgery Under General Anaesthesia [PDF]

open access: yes, 2019
Background: Postoperative nausea and vomiting are common and distressing postsurgical symptoms. These symptoms are of particular concern in outpatient surgery because they may require additional direct resources, such as supplies and antiemetic ...
Bhatti, S. U. (Sami)   +5 more
core   +2 more sources

The use of aprepitant in the first cycle of moderately emetogenic chemotherapy in patients with colorectal cancer: its preventive effect on chemotherapy-induced nausea and vomiting [PDF]

open access: yesKorean Journal of Clinical Oncology, 2013
Purpose: There have been fever studies about the effectiveness of aprepitant in the first cycle of moderately emetogenic chemotherapy. The aim of this study was to determine whether aprepitant shows the effectiveness for prevention of chemotherapy ...
Jung Won Ryu   +4 more
doaj   +1 more source

Management of Adverse Effects of Chemotherapy in Ovarian Cancer through Ayurveda: A Case Report [PDF]

open access: yesJournal of Clinical and Diagnostic Research, 2023
Cancer is a condition where abnormal cells multiply uncontrollably and can invade nearby tissues. Only 30% of women with ovarian cancer can expect to live for more than 5 years, as 70% of cases are diagnosed at an advanced stage.
Pankaj Yadav   +2 more
doaj   +1 more source

Use of Most Bothersome Symptom as a Coprimary Endpoint in Migraine Clinical Trials: A Post-Hoc Analysis of the Pivotal ZOTRIP Randomized, Controlled Trial. [PDF]

open access: yes, 2018
ObjectiveTo better understand the utility of using pain freedom and most bothersome headache-associated symptom (MBS) freedom as co-primary endpoints in clinical trials of acute migraine interventions.BackgroundAdhesive dermally applied microarray (ADAM)
Dodick, David W   +5 more
core   +1 more source

Home - About - Disclaimer - Privacy